Search results
2,065 Shares in GSK plc (NYSE:GSK) Acquired by Scarborough Advisors LLC
ETF DAILY NEWS· 1 day agoScarborough Advisors LLC bought a new position in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to its most recent Form 13F filing ...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 7 days agoModerna stock toppled Monday after the biotech company said its combination Covid and flu vaccine...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 7 days agoGSK GSK announced that the FDA has approved the expanded use of its respiratory syncytial virus...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters· 7 days ago, opens new tab said on Monday its combination vaccine to protect against both COVID-19 and...
FDA Gives Nod to RSV Vaccine for People in Their 50s | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 7 days agoDrugmaker GSK’s Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved...
GSK plc (NYSE:GSK) Shares Bought by Neuberger Berman Group LLC
ETF DAILY NEWS· 6 days agoNeuberger Berman Group LLC grew its stake in shares of GSK plc (NYSE:GSK – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
New RSV shots tied to rare nervous system disorder — should you worry?
Live Science via Yahoo News· 4 days agoThere's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But...
GSK plc (LON:GSK) Insider Julie Brown Acquires 8 Shares
ETF DAILY NEWS· 4 days agoGSK plc (LON:GSK – Get Free Report) insider Julie Brown acquired 8 shares of GSK stock in a transaction on Tuesday, June 11th. The shares ...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 7 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 5 days agoModerna reported that a single dose of mRNA-1083 met immunogenicity non-inferiority criteria versus...